Accordingly, in NSCLC, the occurrence of liver metastases was associated with an immune-suppressive phenotype characterized by fewer infiltrating CD8+ T-cell densities at the invasive margin in distant tumors (66) and limited immunotherapy efficacy by macrophage-mediated elimination of T cells (70). This evidence concerns the gene CD8A and non-small cell lung carcinoma.